AMOEBA SAS, a company operating within the Materials sector, specifically in the Chemicals industry, has recently been the subject of financial analysis due to its performance on the NYSE Euronext Paris. As of June 25, 2026, the company’s close price stood at 0.761 EUR, reflecting a notable fluctuation within the year. The stock reached its 52-week high of 1.198 EUR on October 20, 2025, and its 52-week low of 0.73 EUR on June 11, 2026.
The market capitalization of AMOEBA SAS is currently valued at 52,420,000 EUR. This valuation is critical for investors assessing the company’s size and potential for growth within the competitive chemicals sector. However, the company’s financial health is further scrutinized by its Price Earnings (P/E) ratio, which is reported at -5.45. This negative P/E ratio indicates that the company is currently not generating profits, which could be a point of concern for potential investors.
The financial metrics of AMOEBA SAS highlight the challenges and opportunities within the chemicals industry, particularly for companies listed on the NYSE Euronext Paris. Investors and analysts will likely continue to monitor the company’s performance closely, especially in light of its recent price volatility and negative earnings. The absence of a detailed description in the provided data leaves room for further investigation into the company’s strategic initiatives and market positioning to better understand its future prospects.
